BeyondSpring News

Express News | Beyondspring Presents Updated Efficacy Results From a Phase 2 Iit Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic Nsclc After Progressing on Prior Immune Checkpoint Inhibitors at the 39TH SITC Annual Meeting

ReutersNov 11 08:00 ET

BeyondSpring Presents Updated Efficacy Results From a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

GlobeNewswireNov 11 08:00 ET

Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency

ReutersNov 6 04:27 ET

Goldman Sachs Raises China Economic Growth Forecasts

WSJOct 13 20:53 ET

China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?

Analysts NotebookOct 8 06:04 ET

Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More

Movers and ShakersOct 2 08:02 ET

Express News | Hedge Funds Are Pouring Into ETFs Focusing on Chinese Equities With $2.4 Billion Inflows

Moomoo 24/7Oct 2 05:50 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

BenzingaOct 1 12:31 ET

Express News | U.S.-Listed Chinese Stocks Surge in Overnight Trading Following Politburo's Commitment to Fiscal Support

Moomoo 24/7Sep 26 02:45 ET

US Listed-Chinese Stocks Surge Tuesday on Policy Boost, Who Is Leading the Way

Moomoo NewsSep 25 05:58 ET

Express News | U.S.-Listed Shares of Chinese Firms Jump Premarket After China Announces Stimulus Measures

ReutersSep 24 04:30 ET

BeyondSpring Plinabulin, Merck Keytruda Combo Shows Promise in NSCLC

Seeking AlphaSep 16 17:14 ET

BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024

GlobeNewswireSep 16 07:00 ET

BeyondSpring Presents Efficacy/Safety Results From a Phase 2 Study of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024

BeyondSpringSep 16 00:00 ET

BeyondSpring Presents Final Phase 3 Results For Plinabulin In 2L/3L NSCLC At ISLAC 2024, With Concurrent Publication In The Lancet Respiratory Medicine

BenzingaSep 10 07:44 ET

Express News | Beyondspring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During Esmo Congress 2024 Showcasing Its Lead Anti-Cancer Asset, Plinabulin

ReutersSep 3 07:00 ET

Is BeyondSpring (NASDAQ:BYSI) In A Good Position To Invest In Growth?

Yahoo FinanceAug 31 08:35 ET

BeyondSpring Inc. Reports Mid-Year Financials

TipRanksAug 29 16:58 ET

Express News | Beyondspring-After Series a-3 Financing 1St Close, Co, Seed Technology Limited to Own About 46.9% of Outstanding Equity Interest in Seedtherapeutics

ReutersAug 6 08:30 ET

Express News | Beyondspring Inc - Seed to File Ind for Tau Degrader Program in 2026

ReutersAug 6 07:01 ET